Top 10 Value Stocks To Buy Right Now

tags:CLSD,OXLC,TOR,TWOU,EVA,BNCL,ICLR,PANW,TOWN,AIV, Nothing's Gonna Stop Us Now was the name of a hit song by Starship way back in 1987. And that seems like an appropriate rallying cry for Wall Street bulls now that the Dow has just matched of best streak of consecutive records since...1987.

The Dow finished with a more than 30 point gain Thursday and hit its tenth record closing high in a row.

The Dow has had several 10-day winning streaks in the past few years, most recently in March 2013, according to data from Bespoke Investment Group.

But what makes this rally truly historic is the fact that the market is also continuing to hit new highs during this epic run. That hasn't happened since Ronald Reagan's second term.

The Dow wound up hitting 12 consecutive records in January of 1987, and it went up 13 straight days overall.

Of course, market historians might ominously note that 1987 was also the year that the stock market suffered its worst one-day drop ever, the infamous Black Monday of October 19, a 508-point plunge that wiped out nearly 23% of the index's value.

Top 10 Value Stocks To Buy Right Now: Clearside BioMedical, Inc. (CLSD)

Advisors' Opinion:

• [By Brian Orelli]

  Shares of Clearside Biomedical (NASDAQ:CLSD) are down 26% at 12:47 p.m. EDT after the company announced what it called "positive topline results" from the phase 2 Tybee trial testing its steroid treatment, CLS-TA, in patients with an eye disease called diabetic macular edema.

• [By Ethan Ryder]

  Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

  Get Catabasis Pharmaceuticals alerts: Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

  Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

• [By Keith Noonan]

  Clearside Biomedical, Inc. Stock (NASDAQ:CLSD) stock rose 66.1% in March, according to data provided by S&P Global Market Intelligence.

• [By Lisa Levin]

    

  Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial. scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review. Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd. Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results. Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday. Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results. Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results. Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91. Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results. Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance. Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results. Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday. Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq. Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent
• [By Max Byerly]

  Clearside Biomedical (NASDAQ:CLSD) is scheduled to release its earnings data before the market opens on Wednesday, August 8th. Analysts expect Clearside Biomedical to post earnings of ($0.57) per share for the quarter.

Top 10 Value Stocks To Buy Right Now: Oxford Lane Capital Corp.(OXLC)

Advisors' Opinion:

• [By Logan Wallace]

  Oxford Lane Capital Corp (NASDAQ:OXLC) announced a monthly dividend on Tuesday, May 22nd, Wall Street Journal reports. Stockholders of record on Thursday, September 20th will be given a dividend of 0.135 per share by the investment management company on Friday, September 28th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 14.92%. The ex-dividend date is Wednesday, September 19th.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Oxford Lane Capital (OXLC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Oxford Lane Capital (OXLC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Oxford Lane Capital (OXLC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Press coverage about Oxford Lane Capital (NASDAQ:OXLC) has been trending somewhat negative on Sunday, according to Accern. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Oxford Lane Capital earned a coverage optimism score of -0.08 on Accern’s scale. Accern also gave press coverage about the investment management company an impact score of 45.7441123846945 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Value Stocks To Buy Right Now: Sutor Technology Group Limited(TOR)

Advisors' Opinion:

• [By Logan Wallace]

  Torcoin (TOR) is a PoW/PoS coin that uses the X11 hashing algorithm. Its launch date was July 4th, 2014. Torcoin’s total supply is 1,316,179 coins and its circulating supply is 316,179 coins. The official website for Torcoin is torcoin.org. Torcoin’s official Twitter account is @thetorcoin.

• [By Logan Wallace]

  Torcoin (CURRENCY:TOR) traded flat against the dollar during the one day period ending at 15:00 PM E.T. on September 15th. During the last seven days, Torcoin has traded flat against the dollar. Torcoin has a market cap of $23,561.00 and approximately $0.00 worth of Torcoin was traded on exchanges in the last 24 hours. One Torcoin coin can currently be purchased for about $0.0745 or 0.00000789 BTC on popular cryptocurrency exchanges.

Top 10 Value Stocks To Buy Right Now: 2U, Inc.(TWOU)

Advisors' Opinion:

• [By Steve Symington]

  Shares of 2U (NASDAQ:TWOU) climbed 14.3% in January, according to data from S&P Global Market Intelligence, rebounding from a particularly tough couple of months as the online education platform specialist continued to strike new partnerships.

• [By Stephan Byrd]

  OppenheimerFunds Inc. trimmed its position in shares of 2U (NASDAQ:TWOU) by 1.0% in the first quarter, HoldingsChannel.com reports. The fund owned 568,148 shares of the software maker’s stock after selling 5,649 shares during the period. OppenheimerFunds Inc.’s holdings in 2U were worth $47,741,000 at the end of the most recent quarter.

• [By Logan Wallace]

  Piper Jaffray Companies assumed coverage on shares of 2U (NASDAQ:TWOU) in a research note published on Thursday morning, MarketBeat reports. The firm issued a neutral rating and a $94.00 price objective on the software maker’s stock.

• [By Brian Withers]

  2U Inc.'s (NASDAQ:TWOU) stock has had an amazing run since the company went public, up over 500% since the March 2014 IPO. The online education company posted stellar 2017 results and has continued robust revenue growth in Q1 2018 with 42% year-over-year growth. But the company still hasn't posted a profit, with a net loss of $29.4 million in 2017, compared to a loss of $20.7 million in 2016. First-quarter results posted in early May showed a quarterly net loss of $14.9 million, and is the company projecting a full year net loss between $46.6 million and $44.7 million. 

• [By Todd Campbell]

  I'm always on the lookout for fast-growing stocks to include in my retirement portfolio. Recently, I bought shares in Paycom Software, Inc. (NYSE:PAYC), BioMarin Pharmaceutical (NASDAQ:BMRN), and 2U Inc. (NASDAQ:TWOU). Are these stocks right for your portfolio, too? Read on to learn why I think these companies can deliver market-beating returns.

• [By Steve Symington]

  2U Inc. (NASDAQ:TWOU) announced first-quarter 2018 results on Thursday after the market closed, highlighting not only the strength of its core Graduate Program business, but also the growing influence of its short-course offerings following its acquisition of GetSmarter last year. Shares were up more than 6% on Friday as of this writing, so let's settle in to learn more about what drove the online education-platform company this quarter, as well as what investors should be watching in the year ahead.

Top 10 Value Stocks To Buy Right Now: Enviva Partners, LP(EVA)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Enviva Partners (EVA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Kayne Anderson Capital Advisors LP lifted its holdings in Enviva Partners LP (NYSE:EVA) by 94.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 445,600 shares of the energy company’s stock after purchasing an additional 216,168 shares during the period. Kayne Anderson Capital Advisors LP’s holdings in Enviva Partners were worth $12,960,000 at the end of the most recent reporting period.

• [By Tyler Crowe]

  Typically when a company experiences an "act of God" event like a fire or a flood, investors can shrug off the issue. This past quarter, though, a fire at one of Enviva Partners' (NYSE:EVA) export terminals exposed something incredibly important about the business and some of management's recent decisions.

• [By Stephan Byrd]

  Enviva Partners (NYSE:EVA) had its price objective trimmed by Royal Bank of Canada to $33.00 in a research note issued to investors on Monday. The firm currently has an outperform rating on the energy company’s stock.

Top 10 Value Stocks To Buy Right Now: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors' Opinion:

• [By Ethan Ryder]

  Entegra Financial (NASDAQ: BNCL) and Beneficial Bancorp (NASDAQ:BNCL) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

• [By Ethan Ryder]

  BidaskClub upgraded shares of Beneficial Bancorp (NASDAQ:BNCL) from a sell rating to a hold rating in a report released on Tuesday morning.

  Shares of Beneficial Bancorp opened at $16.35 on Tuesday, MarketBeat.com reports. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $1.23 billion, a P/E ratio of 31.44 and a beta of 0.55. Beneficial Bancorp has a fifty-two week low of $14.40 and a fifty-two week high of $17.50.

• [By Joseph Griffin]

  Media coverage about Beneficial Bancorp (NASDAQ:BNCL) has trended positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Beneficial Bancorp earned a news impact score of 0.38 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 45.8699493506664 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

• [By Joseph Griffin]

  Beneficial Bancorp Inc (NASDAQ:BNCL) Director Thomas J. Lewis sold 973 shares of the company’s stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $16.50, for a total value of $16,054.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

• [By Logan Wallace]

  Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

Top 10 Value Stocks To Buy Right Now: ICON plc(ICLR)

Advisors' Opinion:

• [By Stephan Byrd]

  Icon Plc (NASDAQ:ICLR) hit a new 52-week high on Monday . The stock traded as high as $150.06 and last traded at $149.02, with a volume of 170901 shares. The stock had previously closed at $147.56.

• [By Shane Hupp]

  Icon Plc (NASDAQ:ICLR) – Stock analysts at KeyCorp issued their Q1 2019 EPS estimates for shares of Icon in a report issued on Monday, September 10th. KeyCorp analyst D. Hooker expects that the medical research company will post earnings of $1.66 per share for the quarter. KeyCorp currently has a “Overweight” rating and a $157.00 target price on the stock. KeyCorp also issued estimates for Icon’s Q2 2019 earnings at $1.72 EPS, Q3 2019 earnings at $1.78 EPS and Q4 2019 earnings at $1.84 EPS.

• [By Joseph Griffin]

  Anavex Life Sciences (NASDAQ:AVXL) and Icon (NASDAQ:ICLR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Icon (ICLR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Buy Right Now: Palo Alto Networks, Inc.(PANW)

Advisors' Opinion:

• [By Chris Lange]

  Palo Alto Networks Inc. (NYSE: PANW) is scheduled to release its most recent quarterly results after the markets close on Thursday. Consensus estimates are calling for $1.17 in earnings per share (EPS) and $633.05 million in revenue. The fiscal fourth quarter of last year had EPS of $0.92 and $509.1 million in revenue.

• [By Steve Symington]

  As for individual stocks, a spinoff at Hewlett-Packard Enterprise (NYSE:HPE) drove a deceiving downward move today, and earnings news from Palo Alto Networks (NYSE:PANW) sent shares of the next-gen security specialist higher.

• [By Danny Vena]

  There was a lot to like when Palo Alto Networks (NYSE:PANW) reported its third-quarter financial results. The company generated revenue of $567 million, which grew 31% compared to the prior-year quarter, while adjusted earnings per share of $0.99 soared 62% year over year. Both metrics eclipsed both the company's forecast and analysts' consensus estimates for the quarter.

• [By Steve Symington]

  Palo Alto Networks (NYSE:PANW) announced solid fiscal third-quarter 2018 results on Monday after the market closed, detailing record revenue and increased guidance as the next-generation cybersecurity platform company continues to take market share from competitors. 

• [By Chris Lange]

  Palo Alto Networks Inc. (NYSE: PANW) is set to report its most recent quarterly results on Monday. Analysts are looking for $0.96 in earnings per share (EPS) and $545.68 million in revenue. Shares closed last week at $209.19, with a consensus price target of $205.09 and a 52-week trading range of $126.56 to $211.71.

Top 10 Value Stocks To Buy Right Now: Towne Bank(TOWN)

Advisors' Opinion:

• [By Joseph Griffin]

  John W. Rosenthal Capital Management Inc. grew its stake in shares of TowneBank (NASDAQ:TOWN) by 10.0% in the first quarter, HoldingsChannel.com reports. The firm owned 110,000 shares of the bank’s stock after buying an additional 10,000 shares during the quarter. TowneBank comprises approximately 2.5% of John W. Rosenthal Capital Management Inc.’s holdings, making the stock its 16th largest holding. John W. Rosenthal Capital Management Inc.’s holdings in TowneBank were worth $3,146,000 as of its most recent filing with the SEC.

• [By Max Byerly]

  TowneBank (NASDAQ:TOWN) is scheduled to announce its earnings results before the market opens on Wednesday, July 25th. Analysts expect TowneBank to post earnings of $0.50 per share for the quarter.

• [By Max Byerly]

  TowneBank (NASDAQ:TOWN) had its hold rating reissued by analysts at Brean Capital.

  KeyCorp started coverage on shares of Waste Connections (NYSE:WCN). The firm issued an overweight rating on the stock.

Top 10 Value Stocks To Buy Right Now: Apartment Investment and Management Company(AIV)

Advisors' Opinion:

• [By Ethan Ryder]

  These are some of the headlines that may have effected Accern’s scoring:

  Get Apartment Investment and Management alerts: Jefferies Financial Group Initiates Coverage on Apartment Investment and Management (AIV) (americanbankingnews.com) Free Research Report as Apartment Investment and Management's AFFO Rose 6% (finance.yahoo.com) $245.43 Million in Sales Expected for Apartment Investment and Management Co (AIV) This Quarter (americanbankingnews.com) $0.61 EPS Expected for Apartment Investment and Management Co (AIV) This Quarter (americanbankingnews.com) Apartment Investment and Management (AIV) PT Raised to $48.00 (americanbankingnews.com)

  AIV has been the topic of a number of research reports. Zacks Investment Research lowered shares of Apartment Investment and Management from a “hold” rating to a “sell” rating in a research note on Monday, February 19th. BMO Capital Markets raised shares of Apartment Investment and Management from an “underperform” rating to a “market perform” rating and set a $42.00 target price on the stock in a research note on Friday, March 2nd. SunTrust Banks set a $44.00 target price on shares of Apartment Investment and Management and gave the company a “buy” rating in a research note on Friday, March 2nd. Barclays reaffirmed a “buy” rating and set a $48.00 target price on shares of Apartment Investment and Management in a research note on Tuesday, March 13th. Finally, Zelman & Associates lowered shares of Apartment Investment and Management from a “hold” rating to a “sell” rating in a research note on Thursday, May 10th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $46.00.

• [By Stephan Byrd]

  News headlines about Apartment Investment and Management (NYSE:AIV) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Apartment Investment and Management earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 46.6669103193152 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

• [By Ethan Ryder]

  Apartment Investment and Management (NYSE:AIV)‘s stock had its “hold” rating reiterated by equities researchers at BMO Capital Markets in a research report issued on Thursday. They currently have a $44.00 price target on the real estate investment trust’s stock. BMO Capital Markets’ price target suggests a potential upside of 3.92% from the company’s current price.

• [By Max Byerly]

  Apartment Investment and Management (NYSE:AIV) had its hold rating reiterated by analysts at BMO Capital Markets. They currently have a $47.00 price target on the stock.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Apartment Investment and Management (AIV)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com